857890-39-2 Sell high quality lenvatinib Mesylate produced in China factory 857890-39-2 seller in China
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
lenvatinib Mesylate Basic information
Product Name: | lenvatinib Mesylate |
Synonyms: | lenvatinib Mesylate;lenvatinib Methanesulfonate;E7080 Mesylate;4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate |
CAS: | <a keyword="857890-39-2" "="" style="margin: 0px auto; padding: 0px; border: 0px;">857890-39-2 |
MF: | C21H19ClN4O4.CH4O3S |
MW: | 0 |
EINECS: | |
Product Categories: | FGF receptor antagonist |
Mol File: | Mol File |
lenvatinib Mesylate Chemical Properties |
Safety Information |
lenvatinib Mesylate Usage And Synthesis |
Usage | E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively. |
CAS NO:7647-15-6
CAS NO:420-37-1
CAS NO:13598-36-2
CAS NO:97416-84-7
CAS NO:15761-39-4
CAS NO:118-75-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View